USO DE UN COMPUESTO QUE ALTERA AL RECEPTOR DE INTERLEUQUINA 1 (IL-1) PARA EL TRATAMIENTO DE ENFERMEDADES O TRASTORNOS OFTALMICOS; Y COMPOSICION FARMACEUTICA QUE COMPRENDE EL COMPUESTO IL-1.
摘要
This invention relates to a novel uses of IL-1 compounds in the treatment and/or prevention of ophthalmic diseases or disorders and to methods of treating and/or preventing ophthalmic diseases or disorders in mammals, particularly humans.
申请公布号
CL2007001049(A1)
申请公布日期
2008.03.14
申请号
CL20070001049
申请日期
2007.04.13
申请人
NOVARTIS AG
发明人
YOO, DANA, KEATING, MARK, NEUNER-JEHLE, MARTIN, SCASSELLATI-SFORZOLINI, BALDO, MARKABI, OLIVIER.